Smiths Medical

ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical products used in infusion therapy, vascular access, and vital care applications. ICU Medical’s product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical, Inc. can be found at www.icumed.com.

Our products are used during critical and intensive care, surgery, post-operative care during recovery, and in a series of home infusion therapies.

We offer a number of some of the most respected and easily recognizable brands in the specialty device space: Portex™, Medex™, Deltec™, Level1™, Pneupac™, CADD™, BCI™, Jelco™, Medfusion™ and Surgivet™.

Smiths Medical employs some 7,500 people, with manufacturing concentrated in the US, the UK, Mexico and Italy. Most territories are serviced through wholly-owned local sales and distribution companies.

Smiths Medical is part of Smiths Group, a world leader in the practical application of technologies, delivering products and services for the threat & contraband detection, medical device, energy and communications markets worldwide. Smiths Group employs over 23,000 people in more than 50 countries.

Company’s Keywords:

medical devices